Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Naohiro Nakahara
Observed names:
N Nakahara,
中原直博,
直博 中原
Institution:
Kobe University
Observed institutions:
Eli Lilly (Japan),
Kobe University
OpenAlex ID:
A5028703537
The efficacy of reboxetine as an antidepressant, a meta-analysis of both continuous (mean HAM-D score) and dichotomous (response rate) outcomes.
2008
·
Gandulam Chuluunkhuu
, Naohiro Nakahara
, et al.
·
Institutional Repositories DataBase (IRDB)
·
16
PDF
Remission, response, and relapse rates in patients with acute schizophrenia treated with olanzapine monotherapy or other atypical antipsychotic monotherapy: 12-month prospective observational study
2015
·
Michihiro Takahashi
, Naohiro Nakahara
, et al.
·
Pragmatic and Observational Research
·
12
PDF
Improved outcomes following a switch to olanzapine treatment from risperidone treatment in a 1‐year naturalistic study of schizophrenia patients in Japan
2012
·
Wenyu Ye
, Shinji Fujikoshi
, et al.
·
Psychiatry and Clinical Neurosciences
·
7
PDF
One-year outcomes in schizophrenia after switching from typical antipsychotics to olanzapine in Japan: an observational study
2012
·
Naohiro Nakahara
, Wenyu Ye
, et al.
·
Pragmatic and Observational Research
·
3
PDF
Characteristics of Outpatients Initiated on Olanzapine versus Risperidone in the Treatment of Schizophrenia in Japan: A Healthcare Database Analysis
2011
·
Wenyu Ye
, Naohiro Nakahara
, et al.
·
Clinical Neuropsychopharmacology and Therapeutics
·
3
PDF
Clinical and functional outcomes for patients with schizophrenia treated with olanzapine: One-year naturalistic outcomes for inpatients and outpatients in Japan
2011
·
Haya Ascher-Svanum
, Wenyu Ye
, et al.
·
Clinical Neuropsychopharmacology and Therapeutics
·
1
PDF
Regression analysis of indicating multiple incremental cost-effectiveness ratios for non-small cell lung cancer treatment
2014
·
Naohiro Nakahara
, Isao Kamae
·
Journal of Medical Economics
臨床研究 うつ病患者に併存する疼痛についての実態調査 : 診療報酬請求データベースを用いたレトロスペクティブ研究
2012
·
天平 大坪
, 直博 中原
, et al.
·
診断と治療
3年間のラロキシフェン塩酸塩治療を受けた日本人閉経後骨粗鬆症患者のアウトカム | 文献情報 | J-global 科学技術総合リンクセンター
2011
·
野尻宗子
, 浜谷越郎
, et al.
·
オステオポローシスジャパン
Pmh8 Health-care Utilization Costs Among Schizophrenia Patients Treated With Olanzapine or Risperidone in Japan
2010
·
N Nakahara
, M Kobayashi
, et al.
·
Value in Health
PDF
Pmh9 Characteristics of Outpatients Initiated on Olanzapine Versus Risperidone in the Treatment of Schizophrenia in Japan
2010
·
W Ye
, N Nakahara
, et al.
·
Value in Health
Pmh8 Improved Treatment Outcomes Following a Switch From Risperidone to Olanzapine in a 1-year Naturalistic Study of Schizophrenia Patients in Japan
2010
·
W Ye
, S Fujikoshi
, et al.
·
Value in Health
Pmh10 Long-term Outcomes After Switching From Typical Antipsychotics to Olanzapine Among Schizophrenia Patients in Japan
2010
·
W Ye
, S Fujikoshi
, et al.
·
Value in Health
PDF
タダラフィル特定使用成績調査 (中間報告) 勃起障害に対するタダラフィルの日常診療下での使用における安全性及び有効性の検討
2009
·
聡 山中
, 直博 中原
, et al.
·
日本性機能学会雑誌 = The japanese journal of Impotence Research
Pmh3 Effectiveness of Olanzapine Treatment for Schizophrenia: 12-month Results of the Post Marketing Surveillance in Japan
2007
·
N Nakahara
, N Takagaki
, et al.
·
Value in Health
PDF
くすりとエビデンス(41)エビデンスをつかう(13)つかっていくら?--薬剤コストにはいろいろある
2006
·
直博 中原
, 美和子 亀井
, et al.
·
EBMジャ-ナル
Pmh13 the Cost-effectiveness of Paroxetine in Treatment of Major Depressive Disorder in Japan
2004
·
N Nakahara
, I Kamae
, et al.
·
Value in Health
PDF
薬剤経済学分析の進め方(6)イギリスの医療制度とnice
2004
·
直博 中原
·
ファームステージ
Pmd2 Monte-carlo Validation of Delta-k Method for Sample-size Calculation in a Cost-effectiveness Trial
2004
·
K Nakajo
, L Cai
, et al.
·
Value in Health
薬剤経済学分析の進め方(5)薬剤経済学分析実施の手順とモデリング
2004
·
直博 中原
·
ファームステージ
薬剤経済学分析の進め方(4)費用効果分析の手法
2004
·
直博 中原
·
ファームステージ
薬剤経済学分析の進め方(3)アウトカムの測定(その1)
2004
·
直博 中原
·
ファームステージ
薬剤経済学分析の進め方(2)薬剤経済学分析の進め方--疾病費用研究
2003
·
直博 中原
·
ファームステージ
薬剤経済学(1)薬剤経済学分析の進め方
2003
·
直博 中原
·
ファームステージ
Pma6: the Reduction of Sample Size for a Cost-effectiveness Trial Using a New Method: the Eight Cases in Japan
2001
·
I Kamae
, S Yanagisawa
, et al.
·
Value in Health
Show more works
View as search
Works count:
25
Citation count:
42
H-index:
3
I10-index:
2
Year
Topic
Type